Shopping Cart
- Remove All
Your shopping cart is currently empty
Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $48 | In Stock | |
| 50 mg | $74 | In Stock | |
| 100 mg | $112 | In Stock | |
| 200 mg | $189 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $29 | In Stock |
| Description | Necroptosis-IN-3 (Cyclohexanecarboxamide, N-(2-thienylmethyl)-) (Compound 69) is a Necroptosis inhibitor that inhibits TNF-α induced necroptosis. Necroptosis-IN-3 (Compound STX1638) also inhibits 11β-HSD1. |
| In vitro | TNF-α-IN-8 (Compound 69) (0.030-100 μM; 24 h) inhibits TNF-α-induced necrosis in FADD-deficient human Jurkat T cells [1]. |
| Synonyms | Cyclohexanecarboxamide, N-(2-thienylmethyl)- |
| Molecular Weight | 223.33 |
| Formula | C12H17NOS |
| Cas No. | 547698-18-0 |
| Smiles | C(NCC1=CC=CS1)(=O)C2CCCCC2 |
| Relative Density. | 1.135 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (246.27 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.